{"id":"W2012980289","doi":"10.1067/mjd.2002.127247","title":"A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":347,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Tolerability; Psoriasis Area and Severity Index; Psoriasis; Placebo; Plaque psoriasis; Adverse effect; Dermatology; Surgery; Anesthesia; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000918264,0.0002499312,0.002818199,0.0003034154,0.0000667659,0.000003044982,0.000367769,0.0001465111,0.00007356216],"category_scores_gemma":[0.0002498471,0.0001461636,0.0002798104,0.0003060579,0.001219047,0.0000919598,0.00007548052,0.0004005421,0.000001232489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005010693,"about_ca_system_score_gemma":0.00009473923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006077417,"about_ca_topic_score_gemma":0.00001215594,"domain_scores_codex":[0.9956502,0.00206611,0.001650247,0.0002058149,0.0001588619,0.0002687785],"domain_scores_gemma":[0.9942528,0.001555414,0.003828302,0.0001873176,0.000142948,0.00003320678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8848609,0.003488913,0.09560154,0.00004216086,0.002977974,0.000003617574,0.001952981,0.000133535,0.003362041,0.00001438126,0.0000625334,0.007499467],"study_design_scores_gemma":[0.9626257,0.002632694,0.02281473,0.0001125536,0.001693661,0.0001526452,0.0005259863,0.00004197888,0.009239443,0.00001577907,0.00001291174,0.0001318591],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942122,0.003260923,0.000008174032,0.0005676509,0.0001226396,0.001784176,0.00001489708,0.000004134236,0.00002517434],"genre_scores_gemma":[0.9995465,0.0002768546,0.00007453653,0.0000274354,0.00001530464,0.00002749149,0.000001594687,0.00001248995,0.00001780675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07776491,"threshold_uncertainty_score":0.5960379,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03022305742770866,"score_gpt":0.320761134649429,"score_spread":0.2905380772217204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}